Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 01/02/2026
Chief Executive Officer - 20/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 58 31/10/2019
Corporate Officer/Principal 58 20/10/2025

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 31/12/2016
Director/Board Member 60 06/05/2021
Chairman 61 04/05/2023
Director/Board Member 60 04/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 55 22/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 15 M kr
9.926 %
3,266,170 9.926 % 12 M kr
Cervantes Capital AB
9.072 %
2,984,997 9.072 % 11 M kr
4.352 %
1,432,078 4.352 % 5 M kr
3.647 %
1,200,000 3.647 % 5 M kr
NameStocks%Valuation
44.01 %
379,762 44.01 % 1 M kr
30.49 %
263,125 30.49 % 986 908 kr
Cervantes Capital AB
13.91 %
120,000 13.91 % 450 086 kr
Svea Bank AB
11.59 %
100,000 11.59 % 375 072 kr

Holdings: C-Rad AB

NameStocks%Valuation
188,5000.57% 707 011 $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.se
address C-Rad AB(CRAD B)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
+1.09%-0.80%+5.08%+32.15% 130M
+3.02%+10.12%+18.86%+2.59% 214B
+1.30%+11.19%-1.92%-23.46% 140B
+1.39%+3.35%-26.75%+10.80% 128B
+1.21%+6.65%-56.48%-10.89% 68.46B
+0.77%-1.03%+6.61%-0.07% 48.18B
+1.01%+4.09%-24.96%-31.74% 45.56B
+1.92%+5.78%+17.57%+11.50% 39.69B
+3.42%+4.45%+26.97%+34.34% 37.69B
+2.90%+6.72%-23.60%-6.37% 30.14B
Average +1.71%+3.98%-5.86%+1.88% 75.18B
Weighted average by Cap. +1.89%+5.29%-4.43%-2.63%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
37.20SEK
Average target price
45.00SEK
Spread / Average Target
+20.97%

Quarterly revenue - Rate of surprise